Seven Eight Capital’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-136,370
Closed -$2.67M 720
2021
Q3
$2.67M Buy
136,370
+112,998
+483% +$4.3M 0.26% 124
2021
Q2
$1.05M Buy
+23,372
New +$1.08M 0.15% 244

Other funds holding CELL

Seven Eight Capital's CELL Position: Q4 2021 in Review

Seven Eight Capital sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 136,370 shares — an estimated $2.67M sold.

Seven Eight Capital first reported a position in CELL in Q2 2021 and held it in 2 quarters. The position peaked at $2.67M in Q3 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.

  • Seven Eight Capital reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Seven Eight Capital sold 136,370 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $2.67M.
  • Seven Eight Capital first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Seven Eight Capital's PhenomeX Inc. Common Stock position peaked at $2.67M in Q3 2021.
  • 132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.

Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.